
You can purchase shares of Century Therapeutics (NASDAQ:IPSC) through any online brokerage.
Other companies in Century Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Century Therapeutics has a consensus price target of $7.29.
The stock price for Century Therapeutics (NASDAQ: IPSC) is $1.1555 last updated November 20, 2026 at 6:11 PM EST.
There are no upcoming dividends for Century Therapeutics.
Century Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Century Therapeutics.
Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its...